Coronavirus is the 2020 material adverse event.

Can the health emergency of COVID-19 have a long-term impact on a company’s value? Can companies engaged in acquisition operations use the Material Adverse Change (MAC) / Material Adverse Events (MAE) clauses as an exit strategy for mitigating investment costs or terminating agreements? Very current questions. Here are some thoughts from experts, including our Andrea Marchetti. Article by Carlotta Scozzari (Business Insider Italia).


Per non perderti le novità e gli approfondimenti di Tonucci & Partners, iscriviti alle nostre newsletter

    I have read the Privacy Policy
    and i authorized the treatment of my personal data

    No Comments
    Leave a Reply